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Hygromycin B (HygB) is one of the aminoglycoside antibiotics, and it is widely
used as a reagent in molecular-biology experiments. Two kinases are known to
inactivate HygB through phosphorylation: aminoglycoside 700-phosphotrans-
ferase-Ia [APH(700)-Ia] from Streptomyces hygroscopicus and aminoglycoside 4-
phosphotransferase-Ia [APH(4)-Ia] from Escherichia coli. They phosphorylate
the hydroxyl groups at positions 700 and 4 of the HygB molecule, respectively.
Previously, the crystal structure of APH(4)-Ia was reported as a ternary complex
with HygB and 50-adenylyl-,-imidodiphosphate (AMP-PNP). To investigate
the differences in the substrate-recognition mechanism between APH(700)-Ia
and APH(4)-Ia, the crystal structure of APH(700)-Ia complexed with HygB is
reported. The overall structure of APH(700)-Ia is similar to those of other
aminoglycoside phosphotransferases, including APH(4)-Ia, and consists of an
N-terminal lobe (N-lobe) and a C-terminal lobe (C-lobe). The latter also
comprises a core and a helical domain. Accordingly, the APH(700)-Ia and
APH(4)-Ia structures fit globally when the structures are superposed at three
catalytically important conserved residues, His, Asp and Asn, in the Brenner
motif, which is conserved in aminoglycoside phosphotransferases as well as in
eukaryotic protein kinases. On the other hand, the phosphorylated hydroxyl
groups of HygB in both structures come close to the Asp residue, and the HygB
molecules in each structure lie in opposite directions. These molecules were held
by the helical domain in the C-lobe, which exhibited structural differences
between the two kinases. Furthermore, based on the crystal structures of
APH(70 0)-Ia and APH(4)-Ia, some mutated residues in their thermostable
mutants reported previously were located at the same positions in the two
enzymes.
1. Introduction
Aminoglycoside antibiotics target 16S rRNA (Woodcock et
al., 1991; Fourmy et al., 1996), resulting in the mistranslation of
mRNA and the blocking of tRNA translocation (Borovin-
skaya et al., 2008; Wilson, 2014). Aminoglycoside antibiotics
have been used with cell-wall-active agents such as penicillin
antibiotics to provide a synergistic effect (Murray, 1990).
However, bacteria evolve to acquire drug resistance by the
methylation of 16S rRNA (Wachino & Arakawa, 2012) or the
modification of antibiotics. Aminoglycoside antibiotics are
modified by acetyltransferases (AACs), adenyltransferases
(ANTs) and phosphotransferases (APHs) (Ramirez &
Tolmasky, 2010). These aminoglycosidase-modifying enzymes
(AMEs) cause dysfunction of antibiotics by preventing their
binding to 16S rRNA in the ribosome, resulting in the survival
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of pathogenic bacteria. Furthermore, some AMEs have been
found to be bifunctional enzymes. For example, AAC(60)-Ie/
APH(200)-Ia exhibits both acetyltransferase and phospho-
transferase activities using different domains (Ferretti et al.,
1986; Boehr et al., 2004).
Aminoglycoside phosphotransferases (APHs) catalyze the
transfer of a phosphate group from ATP to the specific posi-
tion of a hydroxyl group in antibiotic molecules. APH(200) and
APH(30) target kanamycin, APH(4)-Ia and APH(700)-Ia target
hygromyin B (HygB), APH(6) targets streptomycin and
APH(9)-Ia targets spectinomycin (Ramirez & Tolmasky,
2010). Some APHs can use either GTP alone or both ATP/
GTP as the phosphate-group donor, such as APH(200)-Ia and
APH(200)-IVa, respectively (Toth et al., 2009). The APH
family, represented by serine/threonine and tyrosine protein
kinases in eukaryotes, contains Brenner’s motif (HxDxxxxN;
Brenner, 1978) as a conserved catalytic motif. The Asp residue
in the motif transfers the phosphate group (Madhusudan et al.,
1994; Cole et al., 1995; Hon et al., 1997; Iino et al., 2013). To
investigate their substrate-recognition mechanisms and to
exploit drug design, crystal structures of APHs have been
determined. The overall structures of APHs are similar to
those of eukaryotic protein kinases (ePKs; Hon et al., 1997),
which are mainly composed of two lobes: an N-lobe for ATP
binding and a C-lobe for substrate binding. Accordingly,
several ePK inhibitors inhibit APHs in vitro (Daigle et al.,
1997; Fong et al., 2011).
Among those phosphotransferases, APH(4)-Ia and
APH(700)-Ia target the same substrate, hygromycin B (HygB;
Rao et al., 1983; Pardo et al., 1985), which is one of the
aminoglycoside antibiotics synthesized by Streptomyces
hygroscopicus (Pittenger et al., 1953). HygB consists of three
rings, a hyosamine ring, a d-talose ring and a destomic acid
ring (Fig. 1), and it is active against both prokaryotic and
eukaryotic cells. It is not currently used for clinical purposes,
but it is widely used as a tool in the cloning of genes for
both prokaryotes and eukaryotes in molecular-biology
experiments (Addgene; http://www.addgene.org). To elucidate
the inactivation mechanism of HygB, the crystal structure of
APH(4)-Ia from Escherichia coli in a ternary complex with
HygB and 50-adenylyl-,-imidodiphosphate (AMP-PNP) has
been reported (Stogios et al., 2011; Iino et al., 2013). In this
structure, the hydroxyl O atom at position 4 in the hyosamine
ring was located between Asp198 in Brenner’s motif and the
-phosphate of AMP-PNP. Since APH(4)-Ia and APH(700)-Ia
show low homology in amino-acid sequence, we determined
the crystal structure of APH(700)-Ia to elucidate the
mechanism of phosphorylation of HygB at a different position
to APH(4)-Ia. Furthermore, a thermostable mutant of
APH(700)-Ia has been obtained which exhibited a 13C higher
optimum temperature than that of the wild type (Sugimoto et
al., 2013). Therefore, the crystal structure is also attractive to
elucidate the thermostabilization mechanism of the mutant
enzyme.
2. Materials and methods
2.1. Cloning, expression and purification of APH(70 0)-Ia
The gene encoding APH(700)-Ia (EC 2.7.1.119) from
S. hygroscopicus had been cloned into pET-21a(+) vector
(Novagen) with a C-terminal 6His tag as reported previously
(Sugimoto et al., 2013). The expression plasmid for APH(700)-
Ia was transformed into the E. coli B834(DE3) strain to
introduce selenomethionine (SeMet) into the enzyme.
E. coli cells harboring the expression plasmid were cultured
in LeMaster medium containing 50 mg ml1 ampicillin and
34 mg ml1 chloramphenicol at 37C. Thiamine hydrochloride
was used as a vitamin solution. Antifoam (Sigma–Aldrich) and
200 mM isopropyl -d-1-thiogalactopyranoside (IPTG) were
added for induction of the target protein when the OD600
reached 0.6–0.8. After 16 h of culture, the cells were harvested
by centrifugation at 4648g for 15 min at 4C.
The cells were resuspended in buffer [20 mM Tris–HCl pH
7.5, 20 mM imidazole, 200 mM NaCl, 10 mM dithiothreitol
(DTT)] and homogenized by ultrasonication. The supernatant
was separated by centrifugation at 69 673g for 40 min followed
by purification using a nickel agarose column (Qiagen). The
elution fraction was dialyzed with a buffer consisting of 50 mM
Tris–HCl pH 8.5, 10% glycerol. An anion-exchange Mono Q
column (GE Healthcare) was used for gradient elution with a
buffer consisting of 50 mM Tris–HCl pH 8.5, 10% glycerol,
500 mM KCl. The purified protein was concentrated to
25 mg ml1 by ultrafiltration at 4C at 4000g.
2.2. Crystallization
Crystallizations were performed by the hanging-drop vapor-
diffusion method at 20C. Protein solution consisting of
2.5 mM MgCl2 (Wako), 10 mM hygromycin B (Wako) and
5 mM AMP-PNP (Sigma–Aldrich) and reservoir solution
were mixed in a 1:1 ratio. After optimization of the reservoir
conditions, crystals grew to dimensions of 0.3  0.3  0.2 mm
in a week using a reservoir solution consisting of 0.1M
2-(cyclohexylamino)ethanesulfonic acid (CHES) pH 8.8, 1.38–
1.40M sodium citrate tribasic. Dithiothreitol or -mercapto-
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Figure 1
Structure of hygromycin B. The hyosamine, d-talose and destomic acid
rings are denoted A, B and C, respectively. The hydroxyl groups at
positions 4 and 70 0 (labelled in red) are phosphorylated by APH(4)-Ia and
APH(70 0)-Ia, respectively.
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ethanol were not added to the reservoir solution to avoid the
oxidation of Se atoms as they prevented the formation of
crystals. We also prepared crystals of native APH(700)-Ia
protein and tried to collect diffraction data; however, only
data sets with lower resolution than that of the SeMet-
derivative crystals were obtained.
2.3. Data collection and structure determination
Crystals were flash-cooled in liquid N2 in nylon loops
without cryoprotectant solution. The diffraction data were
collected on beamline BL-17A equipped with a PILATUS3
S6M detector at the Photon Factory (PF). Since the crystals
diffracted poorly and produced weak anomalous diffraction,
we repeated the data-set collection. A single crystal was used
to solve the phase and for model refinement. To increase the
resolution, the data were collected with a large redundancy.
Indexing, integration, scaling and merging were carried out
using the XDS package (Kabsch, 2010). The Se-SAD phasing
and automated initial model building of APH(700)-Ia were
performed using CRANK2 (Skuba´k & Pannu, 2013) in the
CCP4 suite (Winn et al., 2011). Iterative refinement and model
building were carried out using PHENIX (Adams et al., 2010)
and Coot (Emsley et al., 2010), respectively. In a Ramachan-
dran plot produced by RAMPAGE (Lovell et al., 2003) in the
CCP4 suite for the final model, 97.1%, 2.9% and 0% of the
residues were in the preferred, allowed and outlier regions,
respectively. Data-collection and refinement statistics are
presented in Table 1.
3. Results and discussion
3.1. Overall structure
To gain an understanding of the phosphorylation
mechanism of the hydroxyl group at position 700 of hygromycin
B (HygB) compared with position 4, the crystal structure of
APH(700)-Ia was solved for the first time. A selenomethionine-
substituted crystal was obtained as molecular-replacement
trials failed despite the similarity of the overall structures of
APHs; this was probably because of the differing conforma-
tion of the C-lobes, as described in Section 3.3. The crystal of
APH(700)-Ia belonged to space group P23 and the crystal
structure was determined at 2.4 A˚ resolution. SHELXD in
CRANK2 used the anomalous reflections above 3.36 A˚ reso-
lution, found all six Se sites except for the methionines at the
N-termini and automatically built 660 residues in six chains
including 30 unknown residues (UNK) out of the 664 residues
in the asymmetric unit. The values of FOM were 0.304 and
0.568 prior to and after density modification, respectively. The
final model comprised two molecules in the asymmetric unit
[Fig. 2(a)] and comprised residues 3–327 in chain A and 4–327
in chain B out of 332 residues, according to the resolved
electron density. The overall structure of APH(70 0)-Ia was
similar to known APH structures, including the reported
binary (Stogios et al., 2011) and ternary (Iino et al., 2013)
complexes of APH(4)-Ia, as well as those of ePKs. APH(700)-
Ia is composed of an N-lobe consisting of a five-stranded
antiparallel -sheet, which is sandwiched by two -helices, and
a C-lobe consisting of ten -helices with five -strands, which
comprise two sets of antiparallel -sheets. The C-lobe consists
of a core domain, which includes Brenner’s motif, and a helical
domain [Fig. 2(a)]. Chains A and B of the APH(700)-Ia crystal
structure in the asymmetric unit were superposed using
LSQKAB (Kabsch, 1976) in the CCP4 suite; the root-mean-
square deviation (r.m.s.d.) value was 1.75 A˚ for the C atoms
of residues 4–327. Differences were mainly observed in the
N-lobe, which is known to be a nucleotide-binding lobe. When
chains A and B were compared by the superposition of either
residues 13–124 (the N-lobe) or 125–326 (the C-lobe) on C
atoms, the r.m.s.d. values for the regions were 2.34 and 0.29 A˚
[Fig. 2(b)], respectively. This structural difference between the
two chains may be caused by the crystal packing.
The electrostatic surface potential of APH(700)-Ia was
calculated and observed to be same as in other APHs, in which
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Table 1
Data-collection and refinement statistics for APH(70 0)-Ia.
Values in parentheses are for the highest resolution shell.
Data collection
Beamline BL-17A, PF
Wavelength (A˚) 0.97934
Space group P23
Unit-cell parameters (A˚) a = b = c = 151.6
Resolution range (A˚) 50.0–2.4 (2.46–2.40)
Completeness (%) 100 (100)
hI/(I)i 31.2 (1.1)
Multiplicity 62.7 (64.6)
Rmerge† (%) 13.2 (459.5)
No. of unique reflections 88021 (6572)
CC1/2 (%) 100 (49.5)
Significant anomalous correlation‡ (%) 47 [15 at 2.98 A˚]
Mean anomalous difference§ 1.475 [3.39 A˚]
Refinement
Resolution range (A˚) 47.9–2.4 (2.45–2.40)
No. of reflections 45592
R/Rfree} (%) 22.5/25.1
R.m.s.d. from ideality
Bond lengths (A˚) 0.003
Bond angles () 0.725
No. of atoms
Protein 5137
Solvent 21
Ligand (hygromycin B) 72
Ligand (CHES) 26
Ligand (citrate) 26
Average B factor (A˚2)
Protein 103.3
Solvent 68.2
Ligand (hygromycin B) 114.2
Ligand (CHES) 134.6
Ligand (citrate) 66.2
Ramachandran plot†† (%)
Favored 97.1
Allowed 2.9
Outliers 0
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith measure-
ment of reflection hkl. ‡ Percentage of correlation between intensities from random
half data sets calculated by XSCALE. Correlation significant at the 0.1% level was
limited to 2.98 A˚ resolution and the corresponding value is presented. § Mean
anomalous difference as reported as SigAno in XSCALE. Since SHELXD used
anomalous data at 3.36 A˚ resolution, the value for the closest resolution shell in
XSCALE is presented in brackets. } A subset of the data (5%) was excluded from
refinement and was used to calculate Rfree. †† The Ramachandran plot was calculated
by RAMPAGE in the CCP4 suite.
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the binding site of HygB in the core domain was negatively
charged [Fig. 2(c)] (Stogios et al., 2011), which complements
aminoglycosides with amines on the sugar rings (Nurizzo et al.,
2003); however, APH(9)-Ia is an exception as it does
not possess such a negatively charged area for antibiotic
binding.
In the crystal structure that we obtained, two citrate ions
originating from the crystallization buffer were observed
between the chains in the asymmetric unit. As shown in
Fig. 2(d), the Gln279 residues in each chain formed hydrogen
bonds to the citrate ion in the other chain. Therefore, these
ions contribute to the formation of a dimer of APH(700)-Ia in
research communications
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Figure 2
Overall structure of APH(70 0)-Ia. (a) The crystal structure of APH(70 0)-Ia in the asymmetric unit is shown as a cartoon model. One chain is colored cyan
and the other is colored light green, green and dark green corresponding to the N-lobe and the core and helical domains in the C-lobe, respectively. HygB
and CHES are shown as stick models. The bottom view shows dyad symmetry between the two chains. (b) ChainsA and B were superposed by LSQKAB
on C atoms in the C-lobe (residues 125–327). Chains A and B are colored magenta and blue, respectively. N and C denote the N- and C-termini,
respectively, and HygB and CHES are also shown as stick models. (c) The electrostatic surface potential was calculated by APBS (Baker et al., 2001) in
PyMOL (Jurrus et al., 2018) and mapped onto the subunit surface. (d) The interactions between the two chains are through the citrate ions. The dotted
rectangle in the left panel was enlarged and rotated 90 in the right panel. Chains A and B are colored green and cyan, respectively. Citrate ions are
denoted Cit and are colored yellow. The dotted lines in the right panel represent hydrogen bonds, where black and red lines indicate distances of below
3 A˚ and between 3 and 3.5 A˚, respectively. All figures except for Figs. 1 and 5 were prepared by PyMOL (Schro¨dinger).
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the asymmetric unit. On the other hand, in solution the ions
may not be fixed in these positions; therefore, APH(70 0)-Ia is
likely to exist as a monomer. PISA (Krissinel & Henrick,
2007) also produced the same result.
3.2. Active site of APH(70 0)-Ia complexed with hygromycin B
Electron density for HygB in chain A was fully observed,
whereas that at the expected AMP-PNP binding site was
partial for the nucleotide. After model refinement, the partial
electron density was assumed to correspond to CHES origi-
nating from the crystallization buffer [Fig. 3(a)]. Electron
density for CHES in chain B was not observed. The residues in
Brenner’s motif were also clearly modeled based on the
observed electron density [Fig. 3(b)]. The binding mode of
HygB in chain A involved hydrogen bonds to Ser78, Asp223,
Thr245, Asp246, Asp298, Glu300 and Glu303. Hygromycin B
also made hydrophobic interactions between the destomic
ring and Phe299 and between the hyosamine ring and Trp73
(Fig. 4). Among these residues, Asp223 is a catalytic residue in
Brenner’s motif in APH(700)-Ia, and the distance between
Asp223 OD2 and the 700 O atom of HygB, which is phos-
phorylated by APH(700)-Ia, was 3.1 A˚. Lys67, which is one of
the conserved residues in the N-lobe that interacts with a
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Figure 3
Hygromycin B and CHES at the active site of APH(70 0)-Ia. (a) HygB and CHES are presented as stick models with an Fo  Fc OMIT map contoured at
2 that was calculated excluding the two molecules. (b) The residues in Brenner’s motif (His221–Asn228) are presented as stick models colored green
and gray with an Fo  Fc OMIT map contoured at 3 that was calculated excluding the residues. The three catalytically important residues are colored
green and labeled. HygB and CHES are depicted as stick models in yellow to represent their relative positions to the residues.
Figure 4
Binding mode of HygB in the active site. (a) HygB and CHES are shown as stick models colored yellow. Dotted lines show hydrogen bonds with
distances of less than 3.5 A˚, and the hydroxyl O atom interacting with Asp223 is the site of phosphorylation by APH(70 0)-Ia. (b) Schematic
representation of the binding mode of HygB and CHES as shown in (a).
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phosphate moiety of ATP in ePKs and APHs to enhance the
binding affinity of ATP (Hon et al., 1997), showed distances of
3.2 and 3.3 A˚ between the NZ atom of Lys67 and the O atoms
of the sulfate of CHES (Fig. 4). On the other hand, the
distances between the O atom of the sulfate of CHES and
Asp223 and the 700 O atom in HygB were 4.5 and 4.3 A˚,
respectively. Therefore, the binding mode of HygB obtained in
this study most likely reflects the active mode of APH(700)-Ia.
Although AMP-PNP and magnesium ions were included in
the crystallization buffer, the bound molecule was assumed to
be CHES, based on the shape of the electron density, and to
originate from the buffer. In the complex structures of
APH(30)-IIIa (Burk et al., 2001), APH(9)-Ia (Fong et al., 2010)
and ePKs (Narayana et al., 1997) with ADP/AMP-PNP, one or
two magnesium ions are observed to interact with the phos-
phates in the nucleotides and they are required for the enzy-
matic reaction.
3.3. Comparison of the binding modes of HygB in APH(70 0)-Ia
and APH(4)-Ia
Although the overall structures of APH(700)-Ia and
APH(4)-Ia were similar, the amino-acid sequences of the two
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Figure 5
Sequence alignment between APH(70 0)-Ia and APH(4)-Ia. The sequence alignment was prepared based on a superposition of the crystal structures of
APH(70 0)-Ia (chain A) and APH(4)-Ia (PDB entry 3w0s) by Chimera and the figure was prepared using ESPript (Robert & Gouet, 2014; http://
espript.ibcp.fr). Green dotted lines show the residues at the border between the N- and C-lobes. The blue dotted line shows Brenner’s motif, and the
three blue rectangles indicate the catalytically important residues. Blue and red lines show the regions of the helical domain in the C-lobe for APH(70 0)-Ia
and APH(4)-Ia, respectively, as colored in Fig. 6(a). 8 and 120, which are marked in red and blue, are described in the text and in Fig. 6(a).
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Figure 6
Comparison of the binding mode of HygB in APH(70 0)-Ia and APH(4)-Ia. (a) The crystal structures of APH(70 0)-Ia and APH(4)-Ia (PDB entry 3w0s)
were superposed at the three catalytically important residues. Cyan and orange sticks in the middle of the proteins represent HygB in APH(70 0)-Ia and
APH(4)-Ia, respectively. The helical domains in the C-lobes are colored cyan and red in APH(70 0)-Ia and APH(4)-Ia, respectively. The blue and pink
helices present in the C-lobes represent 120 in APH(70 0)-Ia and 8 in APH(4)-Ia, respectively. (b) HygB and its interacting partner residues are
represented as stick models in blue and cyan for APH(70 0)-Ia and in orange and red for APH(4)-Ia. Red dotted circles show the hydroxyl groups
phosphorylated by APH(70 0)-Ia and APH(4)-Ia. The small green sphere represents a magnesium ion.
Figure 7
Thermostable mutants of APH(70 0)-Ia and APH(4)-Ia. The crystal structures of APH(70 0)-Ia and APH(4)-Ia (PDB entry 3w0s) are superposed at the
three residues in Brenner’s motif. (a) Superposed structures are shown as cartoon models. Residues colored green and orange represent APH(70 0)-Ia and
APH(4)-Ia, respectively. (b) Three residues, His, Asp and Asn, in Brenner’s motif were used to superpose the two enzymes. Residue numbers in green
and orange correspond to APH(70 0)-Ia and APH(4)-Ia, respectively. (c) Part of the core domain in the orange rectangle in (a) is enlarged. The numbered
residues are those that are mutated in the thermostable mutants. Nonlabeled residues are shown as components of the hydrophobic core for both the
APH(70 0)-Ia (green) and APH(4)-Ia (orange) enzymes.
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enzymes showed low homology (Fig. 5). When the structures
of APH(700)-Ia and APH(4)-Ia (PDB entry 3w0s; Iino et al.,
2013) were globally superposed by GESAMT in the CCP4
suite, the r.m.s.d. value was 3.30 A˚ for 251 residues among 325
and 303 residues in APH(700)-Ia and APH(4)-Ia, respectively.
Then, in order to compare the binding modes of HygB in
APH(700)-Ia and APH(4)-Ia (PDB entry 3w0s), the two
structures were superposed at the C atoms of three residues:
His221 in APH(700)-Ia/His196 in APH(4)-Ia, Asp223/Asp198
and Asn221/Asn203 in Brenner’s motif. As shown in Fig. 6(a),
the N-lobes fitted well, whereas large differences were
observed in the C-lobes. The phosphorylated hydroxyl group
was closer to the catalytic Asp residue, while the HygB
molecules in each enzyme were placed in opposite directions.
This difference seemed to reflect the conformational differ-
ence in the C-lobes between the two enzymes. When we
manually tried to place the HygB molecule in APH(700)-Ia at
the position corresponding to that in APH(4)-Ia, there was
interference in -helix 120 (120) in APH(700)-Ia [Figs. 5 and
6(a)]. On the other hand, when it was attempted to manually
place HygB in APH(4)-Ia at the position corresponding to
that in APH(700)-Ia, 8 in APH(4)-Ia interfered. Therefore,
structural differences in the C-lobes seemed to define the
binding modes of HygB in the two enzymes.
Previously, enzyme kinetics have been reported for both
APH(700)-Ia and APH(4)-Ia. The kcat values of APH(700)-Ia
and APH(4)-Ia for HygB are almost the same; on the other
hand, the Km value of APH(7
00)-Ia is about ten times greater
than that of APH(4)-Ia (Sugimoto et al., 2013; Nakamura et al.,
2008). HygB interacted with six residues at the active site in
both cases; however, HygB in APH(4)-Ia and APH(700)-Ia
forms interactions with nine and five atoms, respectively
[Fig. 6(b)]. Therefore, these differences may affect the kinetic
parameters of the enzymes.
3.4. Thermostable mutants of APH(70 0)-Ia and APH(4)-Ia
Thermostable mutants of APH(700)-Ia and APH(4)-Ia have
been reported previously, which exhibit optimum tempera-
tures that are 13 and 5C higher than those of the wild types
(Sugimoto et al., 2013; Nakamura et al., 2008). They are
denoted HYG10 and HPH5 as ten and five residues are
mutated, respectively, in the enzymes, which were obtained by
the directed-evolution method. In order to compare the
mutation sites in the structures, the crystal structures of
APH(700)-Ia and APH(4)-Ia were superposed at the three
residues in Brenner’s motif [Figs. 7(a) and 7(b)]. Several
residues in both structures located in the core domain of the
C-lobe seemed to increase the hydrophobic interactions in the
domain. Interestingly, Ser252 in APH(700)-Ia and Ser225 in
APH(4)-Ia were located at the same position on superposition,
and the serine residues were substituted by prolines in both
thermostable structures [Fig. 7(c)] and are located at the end
of -helices. Therefore, the strengthening of the hydrophobic
core in the core domain seems to be effective in increasing the
thermal stability of the enzymes.
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